Entry characteristics of children who completed the trial
Placebo group (n=26) | Treatment group (n=24) | |
---|---|---|
Values are number (%) or mean (SD). | ||
*p<0.05 (t test). | ||
†Reported eczema or rhinitis excluding wheeze or “asthma” as a diagnosis. | ||
M/F | 16/10 | 13/11 |
Age (months) | 35.6 (8.5) | 36.2 (10.0) |
Recalled symptoms in previous winter | ||
No of episodes | 3.5 (1.8) | 4.2 (6.3) |
Episode duration (days) | 8.6 (6.0) | 12.1 (6.3)* |
Symptoms between episodes | ||
Days per month | 5.0 (4.2) | 6.2 (4.8) |
Nights per month | 8.3 (5.1) | 9.1 (4.1) |
Personal atopy† | 9 (35%) | 5 (21%) |
Parental asthma | 14 (54%) | 13 (54%) |
Maternal smoking | 7 (27%) | 9 (38%) |